Molecule OLE Reprograms Brain Immune Cells to Combat Alzheimer's in Animal Studies

Researchers have identified a new experimental molecule, OLE, that appears to reprogram microglia, the brain's immune cells, into a protective state. In animal models of Alzheimer's disease, this treatment reduced toxic beta-amyloid plaque buildup and improved memory. This discovery offers a promising new therapeutic approach for Alzheimer's disease.